US Stock MarketDetailed Quotes
OMGA Omega Therapeutics
- 2.265
- -0.065-2.79%
Trading Apr 25 12:44 ET
124.93MMarket Cap-1258P/E (TTM)
2.320High2.200Low133.98KVolume2.280Open2.330Pre Close301.46KTurnover0.63%Turnover RatioLossP/E (Static)55.15MShares10.09052wk High2.15P/B48.38MFloat Cap1.30052wk Low--Dividend TTM21.36MShs Float31.410Historical High--Div YieldTTM5.14%Amplitude1.300Historical Low2.250Avg Price1Lot Size
Omega Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 7.11%-91.51M | 29.49%-17.09M | 7.24%-23.04M | 10.81%-23.27M | -20.39%-28.11M | -71.01%-98.52M | -51.90%-24.24M | -50.55%-24.84M | -78.62%-26.09M | -121.35%-23.35M |
| Net income from continuing operations | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M | -39.24%-25.8M | -68.15%-25.91M | -49.50%-20.16M |
| Operating gains losses | ---233K | ---1K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 30.46%6.77M | 35.44%1.78M | 41.11%1.86M | 36.97%1.82M | 6.61%1.31M | 274.19%5.19M | 242.45%1.32M | 262.91%1.32M | 294.07%1.33M | 305.96%1.23M |
| Other non cash items | 81.25%145K | -41.18%20K | 130.00%23K | -54.17%11K | 658.33%91K | -24.53%80K | 173.91%34K | -92.59%10K | 900.00%24K | -40.00%12K |
| Change In working capital | 5.22%-9.37M | -127.31%-806K | -91.53%-4.95M | 173.32%2.86M | -2.02%-6.47M | -311.97%-9.88M | -11.99%2.95M | -364.27%-2.59M | -1,620.26%-3.91M | -403.01%-6.34M |
| -Change in receivables | -1,422.93%-5.51M | -57,440.00%-5.73M | 1,810.64%804K | -288.24%-726K | 203.62%143K | -40.86%-362K | 103.89%10K | ---47K | ---187K | ---138K |
| -Change in prepaid assets | 116.50%1.42M | 1,001.30%2.08M | 55.02%-1.46M | 102.41%86K | 145.11%705K | -224.72%-8.59M | -129.50%-231K | -1.73%-3.24M | -596.93%-3.56M | -61.80%-1.56M |
| -Change in payables and accrued expense | -267.02%-7.05M | -115.21%-653K | -444.91%-3.79M | 1,908.96%4.26M | -394.38%-6.86M | -43.15%4.22M | 48.60%4.29M | -24.45%1.1M | 705.71%212K | -144.61%-1.39M |
| -Change in other current assets | 102.95%111K | 103.26%25K | 922.64%436K | -1,095.24%-251K | 96.61%-99K | -2,512.18%-3.76M | -368.77%-766K | 32.05%-53K | -250.00%-21K | -6,395.56%-2.92M |
| -Change in other current liabilities | 220.25%1.66M | 1,078.59%3.47M | -168.95%-944K | -45.95%-505K | -9.37%-362K | -13,730.00%-1.38M | -2.31%-355K | -202.93%-351K | -34,700.00%-346K | -6,520.00%-331K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 7.11%-91.51M | 29.49%-17.09M | 7.24%-23.04M | 10.81%-23.27M | -20.39%-28.11M | -71.01%-98.52M | -51.90%-24.24M | -50.55%-24.84M | -78.62%-26.09M | -121.35%-23.35M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 363.10%47.52M | -87.88%2.14M | -106.84%-724K | 113.45%24.05M | 138.30%22.05M | 55.30%-18.06M | 145.11%17.65M | 3,099.43%10.59M | 1,401.04%11.27M | -119,831.25%-57.57M |
| Net PPE purchase and sale | -60.80%-2.22M | -57.88%-461K | -120.73%-724K | -70.07%-1.03M | --0 | 5.93%-1.38M | -46.00%-292K | 7.08%-328K | 29.79%-608K | -216.67%-152K |
| Net investment purchase and sale | 398.17%49.73M | -85.50%2.6M | --0 | 111.23%25.08M | 138.40%22.05M | 57.16%-16.68M | 146.09%17.94M | --10.92M | --11.88M | ---57.42M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 363.10%47.52M | -87.88%2.14M | -106.84%-724K | 113.45%24.05M | 138.30%22.05M | 55.30%-18.06M | 145.11%17.65M | 3,099.43%10.59M | 1,401.04%11.27M | -119,831.25%-57.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5,807.20%41.82M | 177.30%1.63M | -300.00%-8K | 525.71%219K | 48,077.11%39.99M | -99.73%708K | -91.97%586K | -100.00%4K | -70.34%35K | -99.93%83K |
| Net issuance payments of debt | --1.62M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --40M | --0 | --0 | --0 | --40M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -31.07%488K | -99.66%2K | 75.00%7K | 960.00%371K | 30.12%108K | 158.39%708K | 2,447.83%586K | -95.45%4K | -70.34%35K | 84.44%83K |
| Net other financing activities | ---288K | --0 | ---15K | ---152K | ---121K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5,807.20%41.82M | 177.30%1.63M | -300.00%-8K | 525.71%219K | 48,077.11%39.99M | -99.73%708K | -91.97%586K | -100.00%4K | -70.34%35K | -99.93%83K |
| Net cash flow | ||||||||||
| Beginning cash position | -62.02%70.96M | 6.70%82.11M | 16.10%105.88M | -1.04%104.88M | -62.02%70.96M | 702.09%186.82M | -67.20%76.96M | -25.71%91.2M | -23.26%105.99M | 702.09%186.82M |
| Current changes in cash | 98.13%-2.17M | -122.12%-13.33M | -66.88%-23.77M | 106.73%996K | 141.97%33.93M | -170.85%-115.87M | 87.45%-6M | -112.73%-14.24M | 3.68%-14.79M | -170.40%-80.83M |
| End cash Position | -3.06%68.78M | -3.06%68.78M | 6.70%82.11M | 16.10%105.88M | -1.04%104.88M | -62.02%70.96M | -62.02%70.96M | -67.20%76.96M | -25.71%91.2M | -23.26%105.99M |
| Free cash flow | 5.52%-94.38M | 25.80%-18.2M | 5.57%-23.76M | 8.97%-24.31M | -19.61%-28.11M | -69.10%-99.9M | -51.83%-24.53M | -49.34%-25.16M | -72.55%-26.7M | -121.78%-23.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg